Clinical Trials Browser

OTHER_GOV × Interventional × Imatinib Mesylate × Clear all

NCT05722795 2025-07-09

I-CONIC

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00297570 2007-10-10

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Phase 3 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive